Profil
Shannon Inman worked as Vice President-Global Clinical Operations at Genprex, Inc. from 2020 to 2021.
Prior to that, she worked as Vice President-Global Clinical Operations at Kuur Therapeutics Ltd.
She also worked as a Project Manager at Baylor College of Medicine.
In terms of education, Inman received an undergraduate degree from Texas A&M University.
Anciens postes connus de Shannon Inman
Sociétés | Poste | Fin |
---|---|---|
GENPREX, INC. | Chief Tech/Sci/R&D Officer | 01/11/2021 |
Baylor College of Medicine | Corporate Officer/Principal | - |
Kuur Therapeutics Ltd.
Kuur Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Kuur Therapeutics provides clinical cellular therapeutics services. It develops, manufactures and markets personalized cellular immunotherapeutics for infectious disease and cancer. Cell Medica has developed proprietary production technology enabling GMP compliant manufacture of antigen-specific T cells. The company was founded by Gregg Sando in 2006 and is headquartered in London, the United Kingdom. | Chief Tech/Sci/R&D Officer | - |
Formation de Shannon Inman
Texas A&M University | Undergraduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
Sociétés cotées | 1 |
---|---|
GENPREX, INC. | Health Technology |
Entreprise privées | 1 |
---|---|
Kuur Therapeutics Ltd.
Kuur Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Kuur Therapeutics provides clinical cellular therapeutics services. It develops, manufactures and markets personalized cellular immunotherapeutics for infectious disease and cancer. Cell Medica has developed proprietary production technology enabling GMP compliant manufacture of antigen-specific T cells. The company was founded by Gregg Sando in 2006 and is headquartered in London, the United Kingdom. | Health Technology |